Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Angptl4 protein, mouse × CNS × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Breast 3 Genitourinary 2 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Lymphoid 1 Head & Neck 1 Gynecologic 1 CNS 1

Conditions

Interventions

Temozolomide 532 Radiotherapy 340 Bevacizumab 222 Magnetic Resonance Spectroscopy 181 Cyclophosphamide 151 Carboplatin 136 Radiosurgery 133 Etoposide 110 Radiation 105 Irinotecan 102 Vincristine 94 Cisplatin 84 Filgrastim 81 Specimen Handling 77 pembrolizumab 75 Lomustine 73 Nivolumab 72 Topotecan 59 Surgical Procedures, Operative 59 Melphalan 51 Carmustine 50 sargramostim 47 Radiotherapy, Intensity-Modulated 45 Isotretinoin 45 Doxorubicin 45 Peripheral Blood Stem Cell Transplantation 44 Granulocyte Colony-Stimulating Factor 44 Erlotinib Hydrochloride 41 Chemotherapy, Adjuvant 41 Granulocyte-Macrophage Colony-Stimulating Factor 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04461938 2024-10-17

ERGO3

Goethe University

Phase NA Active not recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡